Novel in vitro evidence on the beneficial effect of quercetin treatment in vascular calcification

Vascular calcification is a pathological chronic condition characterized by calcium crystal deposition in the vessel wall and is a recurring event in atherosclerosis, chronic kidney disease, and diabetes. The lack of effective therapeutic treatments opened the research to natural products, which hav...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Ceccherini (Author), I. Gisone (Author), E. Persiani (Author), C. Ippolito (Author), A. Falleni (Author), A. Cecchettini (Author), F. Vozzi (Author)
Format: Book
Published: Frontiers Media S.A., 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_fa5bff9d8d9241738cd0bb7d85ecdab9
042 |a dc 
100 1 0 |a E. Ceccherini  |e author 
700 1 0 |a I. Gisone  |e author 
700 1 0 |a E. Persiani  |e author 
700 1 0 |a C. Ippolito  |e author 
700 1 0 |a A. Falleni  |e author 
700 1 0 |a A. Cecchettini  |e author 
700 1 0 |a A. Cecchettini  |e author 
700 1 0 |a F. Vozzi  |e author 
245 0 0 |a Novel in vitro evidence on the beneficial effect of quercetin treatment in vascular calcification 
260 |b Frontiers Media S.A.,   |c 2024-01-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2024.1330374 
520 |a Vascular calcification is a pathological chronic condition characterized by calcium crystal deposition in the vessel wall and is a recurring event in atherosclerosis, chronic kidney disease, and diabetes. The lack of effective therapeutic treatments opened the research to natural products, which have shown promising potential in inhibiting the pathological process in different experimental models. This study investigated the anti-calcifying effects of Quercetin and Berberine extracts on vascular smooth muscle cells (VSMCs) treated with an inorganic phosphate solution for 7 days. Quercetin has shown the highest anti-calcifying activity, as revealed by the intracellular quantitative assay and morphological analysis. Confocal microscopy revealed downregulation of RUNX2, a key marker for calcified phenotype, which was otherwise upregulated in calcified VSMCs. To investigate the anti-inflammatory activity of Quercetin, culture media were subjected to immunometric assays to quantify the levels of IL-6 and TNF-α, and the caspase-1 activity. As expected, calcified VSMCs released a large quantity of inflammatory mediators, significantly decreasing in the presence of Quercetin. In summary, our findings suggest that Quercetin counteracted calcification by attenuating the VSMC pathological phenotypic switch and reducing the inflammatory response. In our opinion, these preliminary in vitro findings could be the starting point for further investigations into the beneficial effects of Quercetin dietary supplementation against vascular calcification. 
546 |a EN 
690 |a nutraceuticals 
690 |a quercetin 
690 |a vascular calcification 
690 |a VSMCs 
690 |a inflammation 
690 |a in vitro model 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 15 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1330374/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/fa5bff9d8d9241738cd0bb7d85ecdab9  |z Connect to this object online.